Side effects of isoniazid and streptomycine in patients with pulmonary tuberculosis accompanying diabetes mellitus and diabetic foot syndrome

T. Kolpakova, J. Bashkirova, M. Kolpakov (Novosibirsk, Russian Federation)

Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Session: Clinical epidemiology of tuberculosis III
Session type: Thematic Poster Session
Number: 2478
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kolpakova, J. Bashkirova, M. Kolpakov (Novosibirsk, Russian Federation). Side effects of isoniazid and streptomycine in patients with pulmonary tuberculosis accompanying diabetes mellitus and diabetic foot syndrome. Eur Respir J 2008; 32: Suppl. 52, 2478

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The coexisting pulmonary tuberculosis and diabetes mellitus
Source: Eur Respir J 2006; 28: Suppl. 50, 26s
Year: 2006

Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012


Radiological features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011


Pulmonary tuberculosis and diabetes mellitus
Source: Eur Respir J 2006; 28: Suppl. 50, 506s
Year: 2006

Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


Diabetes mellitus as cause of treatment failure and relapses of pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 311s
Year: 2001

Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019


Diagnostical and therapeutical particularities of lung tuberculosis in diabetes mellitus patients
Source: Eur Respir J 2003; 22: Suppl. 45, 339s
Year: 2003

Diagnostic characteristics of pulmonary tuberculosis with diabetes mellitus
Source: Eur Respir J 2002; 20: Suppl. 38, 362s
Year: 2002

Influence of diabetes mellitus on sputum conversion rate in pulmonary tuberculosis and on antituberculous drug resistance
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019


Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004

Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Particular feature of lungs microangiopathy in patients with tuberculosis and diabetes mellitus
Source: Eur Respir J 2002; 20: Suppl. 38, 609s
Year: 2002

Pulmonary tuberculosis and diabetes mellitus in Belgrade
Source: Eur Respir J 2002; 20: Suppl. 38, 364s
Year: 2002

Importance of hereditary predisposition factors in patients with tuberculosis combined with diabetes mellitus
Source: Eur Respir J 2002; 20: Suppl. 38, 556s
Year: 2002

Control of ventilation in patients with insulin-dependent diabetes mellitus complicated by autonomic neuropathy
Source: Eur Respir J 2005; 26: Suppl. 49, 66s
Year: 2005

Pulmonary microangiopathy as a possible complication in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 222s
Year: 2004

Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019